FDA starts moving on critical path, but initiative running out of steam.
Finkelstein
Joel B
JB
D000970:Antineoplastic Agents / Q000191:economics*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000639:trends
D000970:Antineoplastic Agents